RecruitingNCT05452291
Multiomics Biomarkers for Urolithiasis
Exploring Multiomics Biomarkers for Urolithiasis
Sponsor
Chinese University of Hong Kong
Enrollment
1,200 participants
Start Date
May 27, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective case series study. To compare urine sample of recurrent stone-formers and non-stone former by multiomics approach to identify potential markers for stone recurrence.
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- Patients with history of recurrent urinary stone
- Age greater than or equal to 18 years old
- Have more than 2 episodes of radio-opaque stone disease (bilateral stones were counted as two episode)
- Patients with no history of urinary stone disease
- Age greater than or equal to 18 years old
- With no history of urinary calculi, from history and imaging.
Exclusion Criteria6
- Patient refused or unable to provide consent for the study
- Patient with active urinary infection
- Patient with radiolucent stone or infective stone
- Patients with no history of urinary stone disease (for control group)
- Patient refused or unable to provide consent for the study
- Patient with active urinary infection
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05452291
Related Trials
PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones
NCT072727201 location
Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent
NCT072758791 location
Efficacy of Neorenal Forte for the Complete Elimination of Residual Fragments
NCT066512949 locations
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
NCT051000171 location
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
NCT069893202 locations